Cargando…
Skp2 is a novel regulator of LSD1 expression and function in gastric cancer
Autores principales: | Asmamaw, Moges Dessale, Zhang, Li-Rong, Liu, Hong-Min, Shi, Xiao-Jing, Liu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404970/ https://www.ncbi.nlm.nih.gov/pubmed/37554205 http://dx.doi.org/10.1016/j.gendis.2023.01.015 |
Ejemplares similares
-
Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1
por: Hu, Kaizhao, et al.
Publicado: (2021) -
Publisher Correction: Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1
por: Hu, Kaizhao, et al.
Publicado: (2021) -
Inhibition of lysine-specific demethylase 1 (LSD1) prevented tumor growth and metastasis by downregulating PD-L1 expression in lung adenocarcinoma
por: He, Pengxing, et al.
Publicado: (2022) -
Isolation of Two Novel Genes, Down‐regulated in Gastric Cancer
por: Yoshikawa, Yoshie, et al.
Publicado: (2000) -
Bilirubin inhibits lung carcinogenesis by up-regulating cystatin A expression in tumor-infiltrating macrophages
por: Huang, Qingtian, et al.
Publicado: (2023)